Litcius/Paper detail

Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study

Sebastiano Bucello, Pietro Annovazzi, Paolo Ragonese, Marta Altieri, Valeria Barcella, Roberto Bergamaschi, Alessia Bianchi, Giovanna Borriello, Maria Chiara Buscarinu, Graziella Callari, Marco Capobianco, Fioravante Capone, Paola Cavalla, Rosella Cavarretta, Antonio Cortese, Giovanna De Luca, Massimiliano Di Filippo, Vincenzo Dattola, Roberta Fantozzi, Elisabetta Ferraro, Maria Maddalena Filippi, Claudio Gasperini, Luigi Maria Edoardo Grimaldi, Doriana Landi, Marianna Lo Re, Giulia Mallucci, Paolo Manganotti, Girolama Alessandra Marfia, Massimiliano Mirabella, Paola Perini, Marco Pisa, Sabrina Realmuto, Margherita Russo, Valentina Tomassini, Valentina Torri Clerici, Mauro Zaffaroni, Cristina Zuliani, Sofia Zywicki, Massimo Filippi, Luca Prosperini

2021Journal of Neurology22 citationsDOI

Topics & Concepts

TeriflunomideMedicineExpanded Disability Status ScaleMultiple sclerosisInternal medicineTolerabilityNeurologyAdverse effectDiseasePhysical therapyPediatricsFingolimodImmunologyPsychiatryMultiple Sclerosis Research StudiesRheumatoid Arthritis Research and TherapiesPregnancy and Medication Impact
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study | Litcius